Preschool Autism Communication Trial
| ISRCTN | ISRCTN58133827 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN58133827 |
| Protocol serial number | G0401546 |
| Sponsor | University of Manchester (UK) |
| Funders | Medical Research Council (MRC) (UK), Department for Education and Skills (DFES) (UK), Department of Health (DoH) (UK) |
- Submission date
- 20/02/2006
- Registration date
- 03/04/2006
- Last edited
- 31/10/2016
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Mental and Behavioural Disorders
Plain English summary of protocol
Not provided at time of registration
Contact information
Scientific
Academic Department of Child and Adolescent Psychiatry
Booth Hall Children's Hospital
University of Manchester
Manchester
M9 7AA
United Kingdom
| Phone | +44 161 306 7941 |
|---|---|
| jonathan.green@manchester.ac.uk |
Study information
| Primary study design | Interventional |
|---|---|
| Study design | Three-site two-arm single (rater) blinded randomised controlled trial |
| Secondary study design | Randomised controlled trial |
| Study type | Participant information sheet |
| Scientific title | Preschool Autism Communication Trial |
| Study acronym | PACT |
| Study objectives | The main hypothesis is that the addition of a systematic, theory-based preschool family intervention, targeted on known core social communication impairments in autism, will result in significant improvement in autism-specific symptoms compared to Treatment As Usual (TAU). Secondary hypotheses are that: 1. This improvement will be mediated by changes in specific aspects of parent-child communication targeted by the treatment 2. General language development will be accelerated 3. Teacher-observed child adaptation will be improved |
| Ethics approval(s) | Central Manchester Research Ethics Committee, 09/03/2006, ref: 05/Q1407/311 |
| Health condition(s) or problem(s) studied | Autism |
| Intervention | Treatment versus treatment as usual, evaluated on standard autism and behavioural instruments and including health economic analysis. Trial treatment: the PACT intervention targets core social interactive and language/communication impairments in autism, which have been identified in developmental research. The treatment is manualised and staged to reflect the developmental progression of pre-linguistic skills and video feedback is used throughout the treatment. Following the 6-month primary intervention, there is a second 6-month period in which there are monthly booster sessions. These focus on the consolidation and generalisation of treatment gains into everyday routines. TAU: families in both arms of the trial will continue with TAU provided by their services. All aspects of TAU will be measured as part of the economic data collection, which will allow us to evaluate its nature and intensity. |
| Intervention type | Other |
| Primary outcome measure(s) |
Primary outcome measures amended as of 01/08/2007: |
| Key secondary outcome measure(s) |
Added as of 31/07/2007: |
| Completion date | 12/10/2009 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Child |
| Lower age limit | 2 Years |
| Upper age limit | 4 Years |
| Sex | All |
| Target sample size at registration | 144 |
| Key inclusion criteria | Children between the ages of 2 and 4 years 11 months, fulfilling diagnostic criteria for core autistic disorder on both social and communication domains of the Autism Diagnostic Observation Schedule-Generic (ADOS-G) - the primary outcome measure, and on two out of the three functional domains of the Autism Diagnostic Interview-Revised (ADI-R). |
| Key exclusion criteria | 1. Cases where primary language at home is not English 2. Significant hearing or visual impairment in child or adult 3. Clinically severe psychiatric illness in parents We judge that the above features could make a treatment based on dyadic communication unreliable to administer. 4. Children below a threshold of 11-month non-verbal developmental age assessed on the Mullen scales of early learning will also be excluded Additional exclusion criteria added as of 01/08/2007: 5. Twins 6. Epilepsy requiring regular medication |
| Date of first enrolment | 13/02/2006 |
| Date of final enrolment | 12/10/2009 |
Locations
Countries of recruitment
- United Kingdom
- England
Study participating centre
M9 7AA
United Kingdom
Results and Publications
| Individual participant data (IPD) Intention to share | No |
|---|---|
| IPD sharing plan summary | Not provided at time of registration |
| IPD sharing plan |
Study outputs
| Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
|---|---|---|---|---|---|
| Results article | results | 19/06/2010 | Yes | No | |
| Results article | results | 21/12/2015 | Yes | No | |
| Results article | long-term follow-up results | 19/11/2016 | Yes | No | |
| Participant information sheet | Participant information sheet | 11/11/2025 | 11/11/2025 | No | Yes |
| Study website | Study website | 11/11/2025 | 11/11/2025 | No | Yes |
Editorial Notes
31/10/2016: Publication reference added.
23/12/2015: Publication reference added.